| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 857,200 | 1,045,100 | 800,400 | 497,400 | | Cost of Revenue | 311,100 | 492,900 | 354,000 | 112,000 | | | Gross Profit | 546,100 | 552,200 | 446,400 | 385,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 135,600 | 130,200 | 123,200 | 111,100 | | Non Recurring | 10,700 | 2,700 | 6,000 | 2,500 | | Others | 115,200 | 110,700 | 95,700 | 89,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 284,600 | 308,600 | 221,500 | 182,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,600 | 15,700 | (3,800) | 12,700 | | Earnings Before Interest And Taxes | 307,300 | 322,100 | 219,800 | 197,200 | | Interest Expense | 32,500 | 25,600 | 19,200 | 17,300 | | Income Before Tax | 274,800 | 296,500 | 200,600 | 179,900 | | Income Tax Expense | 102,200 | 110,700 | 69,800 | 66,600 | | Minority Interest | (2,100) | (2,400) |
-
|
-
| | | | Net Income From Continuing Ops | 172,600 | 185,800 | 130,800 | 113,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 172,600 | 185,800 | 130,800 | 113,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $172,600 | $185,800 | $130,800 | $113,300 |
|
0.29% Nasdaq 
0.14%
Income Statement
